NAMS Menopause Certification Exam Study Set Latest
Update 2026 100% pass Guarantee
1. Describe how estrogen treatment can alleviate symptoms associated with
Primary Ovarian Insufficiency (POI).
Estrogen treatment has no effect on symptoms related to POI.
Estrogen treatment can help manage symptoms of POI by replacing
the hormones that the ovaries are not producing, thus alleviating
symptoms like hot flashes and vaginal dryness.
Estrogen treatment prevents osteoporosis by directly strengthening
bones.
Estrogen treatment increases testosterone levels, which reduces mood
swings.
2. Describe the relationship between menopause and sleep disturbances in
women.
Menopause only affects physical symptoms, not sleep.
Menopause improves sleep quality in women.
Menopause has no effect on sleep patterns.
Menopause can lead to hormonal changes that disrupt sleep
patterns in women.
3. Describe the circumstances under which non-hormonal treatments for GSM
are typically recommended.
Non-hormonal treatments should only be used after hormonal
treatments have failed.
Non-hormonal treatments are always the first line of treatment for all
menopausal symptoms.
, Non-hormonal treatments for GSM are recommended when
hormonal therapies are contraindicated or not preferred by the
patient.
Non-hormonal treatments are only recommended for women under
50.
4. What is the MOA of Ospemifene?
Binds to ERa and ERb on the vaginal tissues. making the vaginal
tissues thicker and less fragile, which reduces pain during sexual
intercourse
Binds to GABA receptor, increasing GABA-A channel currents,
reducing pain during sexual intercourse
Numbs the vaginal walls, reducing pain during sexual intercourse
5. Which one of the following is true of screening for thyroid disease?
The AACE recommends routine screening for patients older than 50
years.
The US Preventive Services Task Force recommends routine
screening.
The AACE recommends routine screening.
The American Association of Clinical Endocrinologists (AACE)
recommends aggressive case finding for patients with an increased
risk of developing hypothyroidism.
6. If a woman experiencing menopause presents symptoms of fatigue and
weight gain, what role does thyroid disease screening play in her evaluation?
It confirms that menopause is the sole cause of her symptoms.
, It is unnecessary as menopause symptoms are unrelated to thyroid
function.
It provides a definitive diagnosis of menopause.
It helps determine if thyroid dysfunction is contributing to her
symptoms.
7. Discuss the significance of thyroid disease screening in relation to
menopause and women's health.
Thyroid disease screening is only relevant for older women.
Thyroid disease screening is not related to menopause.
Thyroid disease screening is significant as it can help identify
hormonal imbalances that may exacerbate menopause symptoms.
Thyroid disease screening is primarily for men.
8. If a menopausal woman with a history of childhood abuse reports severe
vasomotor symptoms, what management strategy might be most beneficial?
Increased physical exercise alone
Cognitive-behavioral therapy combined with hormone replacement
therapy
Avoiding all medical interventions
Only hormone replacement therapy
9. If a woman experiencing menopause is also facing intimate partner violence,
what management strategy should be prioritized to address both issues?
Hormone replacement therapy only
Ignoring the situation to avoid conflict
Increased physical activity and exercise
, Access to mental health support and safety planning
10. If a woman is experiencing irregular menstrual cycles and hot flashes, which
STRAW stage might she likely be in?
Stage 0
Stage -1
Stage +1
Stage -2
11. Describe how ospemifene functions as a treatment for menopausal
symptoms.
Ospemifene is a hormone replacement therapy that provides systemic
estrogen.
Ospemifene directly increases estrogen production in the ovaries.
Ospemifene acts as a selective estrogen receptor modulator
(SERM) to alleviate vaginal atrophy symptoms.
Ospemifene blocks estrogen receptors to reduce breast cancer risk.
12. Describe the relationship between oral estrogen therapy and thyroid
medication management.
Oral estrogen increases the effectiveness of thyroid medication
without adjustments.
Oral estrogen decreases the need for thyroid medication.
Oral estrogen has no impact on thyroid hormone levels.
Oral estrogen can affect thyroid hormone levels, necessitating
monitoring and potential adjustments in thyroid medication.
Update 2026 100% pass Guarantee
1. Describe how estrogen treatment can alleviate symptoms associated with
Primary Ovarian Insufficiency (POI).
Estrogen treatment has no effect on symptoms related to POI.
Estrogen treatment can help manage symptoms of POI by replacing
the hormones that the ovaries are not producing, thus alleviating
symptoms like hot flashes and vaginal dryness.
Estrogen treatment prevents osteoporosis by directly strengthening
bones.
Estrogen treatment increases testosterone levels, which reduces mood
swings.
2. Describe the relationship between menopause and sleep disturbances in
women.
Menopause only affects physical symptoms, not sleep.
Menopause improves sleep quality in women.
Menopause has no effect on sleep patterns.
Menopause can lead to hormonal changes that disrupt sleep
patterns in women.
3. Describe the circumstances under which non-hormonal treatments for GSM
are typically recommended.
Non-hormonal treatments should only be used after hormonal
treatments have failed.
Non-hormonal treatments are always the first line of treatment for all
menopausal symptoms.
, Non-hormonal treatments for GSM are recommended when
hormonal therapies are contraindicated or not preferred by the
patient.
Non-hormonal treatments are only recommended for women under
50.
4. What is the MOA of Ospemifene?
Binds to ERa and ERb on the vaginal tissues. making the vaginal
tissues thicker and less fragile, which reduces pain during sexual
intercourse
Binds to GABA receptor, increasing GABA-A channel currents,
reducing pain during sexual intercourse
Numbs the vaginal walls, reducing pain during sexual intercourse
5. Which one of the following is true of screening for thyroid disease?
The AACE recommends routine screening for patients older than 50
years.
The US Preventive Services Task Force recommends routine
screening.
The AACE recommends routine screening.
The American Association of Clinical Endocrinologists (AACE)
recommends aggressive case finding for patients with an increased
risk of developing hypothyroidism.
6. If a woman experiencing menopause presents symptoms of fatigue and
weight gain, what role does thyroid disease screening play in her evaluation?
It confirms that menopause is the sole cause of her symptoms.
, It is unnecessary as menopause symptoms are unrelated to thyroid
function.
It provides a definitive diagnosis of menopause.
It helps determine if thyroid dysfunction is contributing to her
symptoms.
7. Discuss the significance of thyroid disease screening in relation to
menopause and women's health.
Thyroid disease screening is only relevant for older women.
Thyroid disease screening is not related to menopause.
Thyroid disease screening is significant as it can help identify
hormonal imbalances that may exacerbate menopause symptoms.
Thyroid disease screening is primarily for men.
8. If a menopausal woman with a history of childhood abuse reports severe
vasomotor symptoms, what management strategy might be most beneficial?
Increased physical exercise alone
Cognitive-behavioral therapy combined with hormone replacement
therapy
Avoiding all medical interventions
Only hormone replacement therapy
9. If a woman experiencing menopause is also facing intimate partner violence,
what management strategy should be prioritized to address both issues?
Hormone replacement therapy only
Ignoring the situation to avoid conflict
Increased physical activity and exercise
, Access to mental health support and safety planning
10. If a woman is experiencing irregular menstrual cycles and hot flashes, which
STRAW stage might she likely be in?
Stage 0
Stage -1
Stage +1
Stage -2
11. Describe how ospemifene functions as a treatment for menopausal
symptoms.
Ospemifene is a hormone replacement therapy that provides systemic
estrogen.
Ospemifene directly increases estrogen production in the ovaries.
Ospemifene acts as a selective estrogen receptor modulator
(SERM) to alleviate vaginal atrophy symptoms.
Ospemifene blocks estrogen receptors to reduce breast cancer risk.
12. Describe the relationship between oral estrogen therapy and thyroid
medication management.
Oral estrogen increases the effectiveness of thyroid medication
without adjustments.
Oral estrogen decreases the need for thyroid medication.
Oral estrogen has no impact on thyroid hormone levels.
Oral estrogen can affect thyroid hormone levels, necessitating
monitoring and potential adjustments in thyroid medication.
